MedPath

Jonsson Comprehensive Cancer Center

🇺🇸United States
Ownership
Subsidiary
Employees
-
Market Cap
-
Website
http://www.cancer.ucla.edu

Bortezomib in Treating Patients With Diffuse Large B-Cell Lymphoma That Is Refractory To Chemotherapy

Phase 2
Completed
Conditions
Lymphoma
First Posted Date
2003-08-07
Last Posted Date
2013-01-08
Lead Sponsor
Jonsson Comprehensive Cancer Center
Target Recruit Count
7
Registration Number
NCT00066508
Locations
🇺🇸

Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, California, United States

BMS-354825 in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Is Resistant to Imatinib Mesylate

Phase 1
Completed
Conditions
Leukemia
First Posted Date
2003-07-09
Last Posted Date
2020-08-03
Lead Sponsor
Jonsson Comprehensive Cancer Center
Target Recruit Count
42
Registration Number
NCT00064233
Locations
🇺🇸

Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, California, United States

Pentostatin Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Kidney Cancer

Phase 1
Completed
Conditions
Kidney Cancer
First Posted Date
2003-06-27
Last Posted Date
2013-01-08
Lead Sponsor
Jonsson Comprehensive Cancer Center
Target Recruit Count
4
Registration Number
NCT00006968
Locations
🇺🇸

Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States

Paclitaxel, Folic Acid, and Lometrexol in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Phase 1
Conditions
Drug/Agent Toxicity by Tissue/Organ
Unspecified Adult Solid Tumor, Protocol Specific
First Posted Date
2003-06-20
Last Posted Date
2013-09-17
Lead Sponsor
Jonsson Comprehensive Cancer Center
Registration Number
NCT00024310
Locations
🇺🇸

Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States

Paclitaxel and Carboplatin With or Without Celecoxib Before Surgery in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer

Phase 2
Completed
Conditions
Lung Cancer
Interventions
First Posted Date
2003-06-06
Last Posted Date
2020-08-03
Lead Sponsor
Jonsson Comprehensive Cancer Center
Target Recruit Count
7
Registration Number
NCT00062179
Locations
🇺🇸

New York Weill Cornell Cancer Center at Cornell University, New York, New York, United States

🇺🇸

Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, California, United States

Dentures and Dental Implants in Treating Patients Undergoing Surgery for Mouth Cancer

Phase 2
Completed
Conditions
Head and Neck Cancer
Interventions
Other: Implant
First Posted Date
2003-05-29
Last Posted Date
2016-02-02
Lead Sponsor
Jonsson Comprehensive Cancer Center
Target Recruit Count
46
Registration Number
NCT00006341
Locations
🇺🇸

Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States

Pomegranate Juice in Treating Patients With Recurrent Prostate Cancer

Not Applicable
Completed
Conditions
Prostate Cancer
Interventions
Dietary Supplement: pomegranate juice
First Posted Date
2003-05-07
Last Posted Date
2021-06-04
Lead Sponsor
Jonsson Comprehensive Cancer Center
Target Recruit Count
47
Registration Number
NCT00060086
Locations
🇺🇸

Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, California, United States

Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Waldenstrom's Macroglobulinemia

Phase 1
Terminated
Conditions
Lymphoma
First Posted Date
2003-05-07
Last Posted Date
2013-01-08
Lead Sponsor
Jonsson Comprehensive Cancer Center
Registration Number
NCT00060294
Locations
🇺🇸

Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States

🇺🇸

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute, Boston, Massachusetts, United States

Radiation Therapy With or Without Surgery in Treating Patients Who Have Brain Metastases

Not Applicable
Completed
Conditions
Metastatic Cancer
First Posted Date
2003-04-25
Last Posted Date
2020-08-03
Lead Sponsor
Jonsson Comprehensive Cancer Center
Target Recruit Count
61
Registration Number
NCT00003324
Locations
🇺🇸

Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States

CP-724,714 in Treating Patients With Metastatic Breast Cancer

Phase 1
Completed
Conditions
Breast Cancer
First Posted Date
2003-03-07
Last Posted Date
2020-08-03
Lead Sponsor
Jonsson Comprehensive Cancer Center
Target Recruit Count
9
Registration Number
NCT00055926
Locations
🇺🇸

Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States

© Copyright 2025. All Rights Reserved by MedPath